Skip to main content

It was only a matter of months ago that psilocybin, the active ingredient in magic mushrooms, was fast tracked by the FDA as a breakthrough treatment for depression. Big business might be the next move for psychedelics with companies like Mind Medicine Inc. and Field Trip Psychedelics Inc. sharing plans to go public.

Mind Medicine, which will be helmed by former Canopy Growth Corp co-CEO Bruce Linton and Shark Tank's Kevin O'Leary, plans to list under the ticker MMED via a reverse takeover by the first week of March. “Our ambition is to be one of the first publicly listed neuro-pharmaceutical companies developing psychedelic medicines,” Rahn told Bloomberg.

Meanwhile, Field Trip raised $8.5 million as part of a series A funding round that wrapped up last week. The company intends to launch a network of ketamine-assisted psychotherapy clinics, according to Executive Chairman Ronan Levy. He and the rest of Field Trip's owners are deciding whether to go public or stick to private funding.

A number of companies are already conducting clinical trials to determine the effectiveness of various psychedelics as treatments for ailments like post-traumatic stress disorder and depression. Compass Pathways, who played no small role in the aforementioned breakthrough treatment status, has not revealed whether it plans to go public.

Scroll to Continue

Recommended Articles

Untold Festival 2022 (Julien Duval)

UNTOLD Wraps Up Explosive 2022 Festival In Romania’s Cluj-Napoca

One of Europe’s largest dance music gatherings, UNTOLD Festival returned with a bang in 2022.

Squambhala 1

ThumpTown Festival Slated for Explosive B.C. Debut In August 2022

The boutique music festival aims to reimagine independent B.C. music gatherings in an unmatched way.

fisherig

Watch FISHER Play Peek-a-Boo With His Baby Goddaughter at a Rave In France

The wholesome moment was one of many for Minnie, who recently joined her Grammy-nominated godfather on his jet-setting tour.

It remains to be seen whether additional U.S. cities will decriminalize psilocybin or other entheogenics over the course of 2020.

Related

Spotify Singed with $1.6 Billion Lawsuit, Files to Take Company Public in 2018

Spotify is facing a massive lawsuit alongside it going public this year.

Excision and Illenium

Illenium to Go B2B with Excision at Bass Canyon 2020

It looks like this is turning into a regular thing.

Psilocybin Mushrooms

FDA Fast-Tracking Psilocybin Mushrooms as Breakthrough Therapy for Depression

The medical benefits of mushrooms are becoming difficult to overlook.

Cheat Codes - Ultra Music Festival 2018

Ultra Music Festival 2020 Postponed Amid COVID-19 Coronavirus Concerns

Ultra organizers and city officials decided to postpone the three-day event for up to a year.

A photo of the Ultra Music Festival main stage at the 2019 event with fire/pyrotechnics shooting out above a crowd.

Ultra Music Festival 2020 Confirmed Canceled

The City of Miami held a press conference confirming that the festival will be postponed until 2021.

Aaron Carter

Aaron Carter Accused of Harassing KRANE and Others

Aaron Carter appears to have threatened KRANE multiple times over a dispute regarding their unfinished collaboration.

Split-screen image of Matthew Koma (real name Matthew Bair) and Zedd (real name Anton Zaslavski).

Matthew Koma Airs Grievances with Zedd in Public Social Media Rant

On the anniversary of "Spectrum," Matthew Koma wrote "...My good feelings towards those songs have all but disappeared..."

A photo of an astronaut art installation as well as a more abstract sculpture at Coachella Valley Music and Arts Festival.

Coachella Confirms 2020 Postponement Amid COVID-19 Concerns

Coachella has joined SXSW and Ultra in canceling their 2020 event amid COVID-19 concerns.